-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Cyclacel Pharmaceuticals - Received Nasdaq Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing On Jan 4

Reuters · 01/06/2023 16:21
BRIEF-Cyclacel Pharmaceuticals - Received Nasdaq Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard Transfer Of Listing On Jan 4

- Cyclacel Pharmaceuticals Inc CYCC.O:

  • CYCLACEL PHARMACEUTICALS - RECEIVED NASDAQ NOTICE OF DELISTING OR FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD; TRANSFER OF LISTING ON JAN 4

Further company coverage: CYCC.O


((Reuters.Briefs@thomsonreuters.com;;))